ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ITCI Intra Cellular Therapies Inc

72.73
0.92 (1.28%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Intra Cellular Therapies Inc NASDAQ:ITCI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.92 1.28% 72.73 71.12 77.46 73.68 71.61 71.61 714,823 22:30:00

Statement of Ownership (sc 13g)

09/02/2021 8:24pm

Edgar (US Regulatory)


SCHEDULE 13G
Amendment No.
Name of Issuer: Intra-Cellular Therapies Inc.
Title of Class of Securities: Common Stock

CUSIP Number: 46116X101
Item 1: Reporting Person: Wasatch Advisors, Inc. 87-0319391
Item 2: Check Box If Member of Group: Not Applicable
Item 3: SEC Use
Item 4: Place of Organization: Utah
Items 5-8: Number of Shares Owned With:
Item 5: Sole Voting Power: 6,333,900
Item 6: Shared Voting Power: 0
Item 7: Sole Dispositive Power: 6,333,900
Item 8: Shared Dispositive Power: 0
Item 9: Aggregate Amount Owned: 6,333,900
Item 10: Check Box If Aggregate Amount Excludes Certain Shares: N/A
Item 11: Percent of Class Owned: 7.9%
Item 12: Type of Reporting Person: IA

Item 1(a): Name of Issuer: Intra-Cellular Therapies Inc.
Item l(b): Address of Issuer:
430 East 29th Street, New York, NY 10016
Item 2(a): Name of Person Filing: Wasatch Advisors, Inc.
Item 2(b): Address: 505 Wakara Way, Salt Lake City, UT 84108
Item 2(c): Citizenship: Not Applicable
Item 2(d): Title of Class of Securities: Common Stock
Item 2(e): CUSIP Number: 46116X101
Item 3(e): Investment Adviser registered under section 203 of the Investment
Advisers Act of 1940
Item 4(a):      Amount Owned: 6,333,900
Item 4(b):      Percent of Class Owned: 7.9%
Item 4(c)(i): Sole Voting Power: 6,333,900
Item 4(c)(ii): Shared Voting Power: 0
Item 4(c)(iii): Sole Dispositive Power: 6,333,900
Item 4(c)(iv): Shared Dispositive Power: 0
Item 5: Check Box If Ownership Is 5% or Less of Class: [ ]
Item 6. Ownership of More Than 5% on Behalf of Another Person: N/A
Item 7: Identification of Subsidiary: Not Applicable
Item 8: Identification of Members of Group: Not Applicable
Item 9: Notice of Dissolution of Group: Not Applicable
Item 10: Certification:
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect
of changing or influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in any transaction
having such purpose or effect.

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct as of December 31, 2020.
Date: 02/09/21
Signature: /s/JB Taylor
Name/Title: JB Taylor/CEO

1 Year Intra Cellular Therapies Chart

1 Year Intra Cellular Therapies Chart

1 Month Intra Cellular Therapies Chart

1 Month Intra Cellular Therapies Chart

Your Recent History

Delayed Upgrade Clock